Clinical Trial Update: A Placebo-controlled Study to Investigate the Safety, and Pharmacokinetics of Oral GSK626616AC in Healthy Subjects [Phase 1]

View source ↗

Summary

This Phase 1, placebo-controlled study evaluated the safety and pharmacokinetics of oral GSK626616AC in healthy subjects. The trial is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia

Drugs mentioned

• GSK626616AC

Snippet

Sponsor: GlaxoSmithKline | Conditions: Healthy Subjects, Anaemia | Phase 1 | Status: COMPLETED